Clinical Trial Update: Clinical and Molecular Staging of Lung Cancer Stages I and IIp

View source ↗

Summary

This update describes the clinical and molecular staging of lung cancer for stages I and IIp in a trial sponsored by Corporacion Parc Tauli.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Corporacion Parc Tauli | Conditions: Lung Cancer | Status: UNKNOWN